$24.30 -0.18 (%) Acorda Therapeutics Inc - NASDAQ

Aug. 26, 2016 | 04:00 PM

Partner Headlines

  1. Seth Klarman Buys 763,889 Shares in Drug Development Company

    GuruFocus | Feb. 15, 2016 | 14:39PM EST
  2. Acorda Therapeutics Confirms It Entered Into A Patent Litigation Settlement Deal With Par Pharma

    Benzinga | Jan. 21, 2016 | 09:29AM EST
  3. Benzinga's M&A Chatter for Tuesday January 19, 2015

    Benzinga | Jan. 19, 2016 | 21:26PM EST
  4. Mid-Afternoon Market Update: US Stocks Turn Red; Crude Oil Falls Over 3%

    Benzinga | Jan. 19, 2016 | 14:48PM EST
  5. Mid-Day Market Update: Dow Surges 150 Points; Progressive Waste Shares Spike Higher

    Benzinga | Jan. 19, 2016 | 12:21PM EST
  6. Mid-Morning Market Update: Markets Open Higher; Bank of America Earnings Top Views

    Benzinga | Jan. 19, 2016 | 10:05AM EST
  7. Acorda Therapeutics To Acquire Biotie Therapies To Boost Its Parkinson's Disease Therapeutic Development

    Benzinga | Jan. 19, 2016 | 09:40AM EST
  8. Acorda to Acquire Biotie Therapies for $25.60/ADS

    Benzinga | Jan. 19, 2016 | 04:15AM EST
  9. Kyle Bass Explains The 'Patent Trolls' Situation In The Pharma Industry

    Benzinga | Jan. 2, 2016 | 20:38PM EST
  10. Acorda to Present New rHIgM22 and AMPYRA Data at 31st Congress of European Committee for Treatment and Research in MS

    Benzinga | Oct. 7, 2015 | 07:05AM EST
  11. Acorda-Allergan surprise deal

    IBD | Oct. 5, 2015 | 18:46PM EST
  12. Acorda, Allergan Make Surprise Deal On Ampyra Patent

    IBD | Oct. 5, 2015 | 15:03PM EST
  13. Benzinga's Volume Movers

    Benzinga | Oct. 5, 2015 | 10:39AM EST
  14. Acorda Therapeutics 8-K Says Co. Agrees With Actavis to Resolve Pending Patent Litigation

    Benzinga | Oct. 5, 2015 | 07:07AM EST
  15. Acorda Therapeutics 8-K Filing Shows Company WIll Oppose Requests To Institute For IPRS, Will Oppose Full Proceedings And Defend Patents

    Benzinga | Sep. 3, 2015 | 16:29PM EST
  16. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 26, 2015 | 08:15AM EST
  17. Mid-Morning Market Update: Markets Open Higher; Best Buy Tops Q2 Views

    Benzinga | Aug. 25, 2015 | 10:47AM EST
  18. Benzinga's Volume Movers

    Benzinga | Aug. 25, 2015 | 10:45AM EST
  19. Morning Market Gainers

    Benzinga | Aug. 25, 2015 | 09:49AM EST
  20. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 25, 2015 | 08:14AM EST
  21. Morning Market Losers

    Benzinga | Jun. 2, 2015 | 09:51AM EST
  22. Acorda Presents Data on First Clinical Study of Remyelinating Antibody for Multiple Sclerosis at American Academy of Neurology Annual Meeting

    Benzinga | Apr. 22, 2015 | 07:32AM EST
  23. Pharmacyclics Shares Fall As Kyle Bass Files Petition To Cancel Patent

    Benzinga | Apr. 20, 2015 | 16:09PM EST
  24. This Analyst Is Defending Acorda Therapeutics; Shares Still Down 7% In A Week

    Benzinga | Feb. 17, 2015 | 17:55PM EST
  25. Acorda

    IBD | Feb. 12, 2015 | 18:30PM EST
  26. Benzinga's Top Initiations

    Benzinga | Feb. 12, 2015 | 10:05AM EST
  27. MLV & Co. Initiates Acorda Therapeutics With Buy

    Benzinga | Feb. 12, 2015 | 09:28AM EST
  28. Earnings Scheduled For February 12, 2015

    Benzinga | Feb. 12, 2015 | 04:29AM EST
  29. Stifel Says Acorda Therapeutics Decline Is 'A Buying Opportunity'

    Benzinga | Feb. 11, 2015 | 17:42PM EST
  30. These 5 Top-Rated Small Cap Stocks Just Hit New Highs

    IBD | Jan. 15, 2015 | 08:02AM EST
  31. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  32. Weekly Review Shows Five Industries Gain In December

    IBD | Jan. 8, 2015 | 18:06PM EST
  33. J.P. Morgan Chimes In With Ratings On BioTech Stocks

    GuruFocus | Jan. 6, 2015 | 12:46PM EST
  34. NeuroDerm Rebounds On Parkinson's Disease Drug Data

    IBD | Dec. 30, 2014 | 12:19PM EST
  35. US Stock Futures Up Ahead Of Economic Data

    Benzinga | Dec. 15, 2014 | 07:23AM EST
  36. Benzinga's Top Initiations

    Benzinga | Dec. 5, 2014 | 09:21AM EST
  37. Goldman Sachs Initiates Acorda Therapeutics With Neutral

    Benzinga | Dec. 5, 2014 | 08:57AM EST
  38. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  39. Civitas Buyout Shores Up Acorda's Wall Street Cred

    IBD | Oct. 28, 2014 | 18:27PM EST
  40. Benzinga's M&A Chatter for Wednesday September 24, 2014

    Benzinga | Sep. 24, 2014 | 21:09PM EST
  41. Acorda up on Civitas purchase

    IBD | Sep. 24, 2014 | 18:14PM EST
  42. Stocks Gain While Dollar Reaches Highest Level Since 2010

    Benzinga | Sep. 24, 2014 | 17:03PM EST
  43. Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat Results

    Benzinga | Sep. 24, 2014 | 15:54PM EST
  44. Acorda To Buy Civitas, Gains Parkinson's Disease Drug

    IBD | Sep. 24, 2014 | 13:27PM EST
  45. U.S. Stocks Rise; Accenture Shares Decline On Weak Forecast

    Benzinga | Sep. 24, 2014 | 13:17PM EST
  46. Markets Edge Lower; KB Home Posts Downbeat Results

    Benzinga | Sep. 24, 2014 | 10:49AM EST
  47. Benzinga's Volume Movers

    Benzinga | Sep. 24, 2014 | 10:14AM EST
  48. Morning Market Movers

    Benzinga | Sep. 24, 2014 | 09:40AM EST
  49. Events for the Week of Sept. 8-12

    Benzinga | Sep. 10, 2014 | 14:34PM EST
  50. Actavis Fuels Growth With Acquisitions, New Generics

    IBD | Jul. 14, 2014 | 17:30PM EST
Trading Center